Profile of individuals who are metabolically healthy obese using different definition criteria. a population-based analysis in the spanish population

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Martínez Larrad, María Teresa ^a,b   Anchuelo, Arturo Corbató N ^a,b   Prado, Ná Yade Del ^b   Rueda, José María Ibarra ^b   Gabriel, Rafael ^c   Serrano Ríos, Manuel ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; LEPTIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CONSENSUS SOCIETIES CRITERIA; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLICALLY HEALTHY OBESE; METABOLICALLY UNHEALTHY OBESE; OBESITY; PREVALENCE; SCORE PROJECT; SENSITIVITY AND SPECIFICITY; SPAIN; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WILDMAN CRITERIA; WILDMAN MODIFIED CRITERIA; HEALTH SURVEY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; RADIOIMMUNOASSAY; SPAIN;

EID: 84910066385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106641     Document Type: Article

References (43)

1. Bray GA. (2003) Risks of obesity. Endocrinol Metab Clin North Am 32 (4): 787-804.
2. Bray GA. (2004) Medical consequences of obesity. J Clin Endocrinol Metab 89 (6): 2583-2589.
3. Sims EA. (2001) Are there persons who are obese, but metabolically healthy? Metabolism 50: 1499-1504.
4. Wildman RP, Mauntner P, Reynols K, McGinn AP, Rajpathak S, et al. (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med168 (15): 1617-1624.
5. Lopez-Garcia E, Guallar-Castillon P, Leon-Mun?oz L, Rodriguez-Artalejo F. (2013) Prevalence and determinants of metabolically healthy obesity in Spain. Atherosclerosis 231: 152-157.
6. Primeau V, Coderre L, Karelis AD, M . Brochu, M-E . Lavoie, et al. (2011) Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 35 (7): 971-981.
7. Blu?her M. (2010) The distinction of metabolically ?healthy? from ?unhealthy? obese individuals. Curr Opin Lipidol 21: 38-43.
8. Pataky Z, Bobbioni-Harsch E, Golay A. (2010) Open questions about metabolically normal obesity. Int J Obes (Lond) 34: S18-S23.
9. Blu?her M. (2012) Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 19: 341-346.
10. Ascaso JF, Romero P, Real TJ, Priego A, Valdecabres C, et al. (2001) Insulin resistance quantification by fasting insulin plasma values and HOMA index in non diabetic population. Med Clin (Barc) 117: 530-533.
11. Hamer M, Stamatakis E. (2012) Metabolically healthy obesity and risk of all cause and cardiovascular disease mortality. J Clin Endocrinol Metab 97 (7): 2482-2488.
12. Alberti KGMM, Eckel R H, Grundy SM, Zimmet P, Cleeman JI, et al. (2009) Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
13. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, et al. (2002) Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 39: 203-208.
14. Marti?nez-Larrad MT, Ferna?ndez Pe?rez C, Gonza?lez Sa?nchez JL, Lopez A, Ferna?ndez-A? lvarez J et al. (2005) Prevalence of the metabolic syndrome (ATPIII criteria) population-based study of rural and urban areas in the Spanish province of Segovia. Med Clin (Barc) 125: 481-486.
15. World Health Organization: WHO MONICA project. Part III: Population survey. Section 1: Population survey data component. In: MONICA manual. 1990 Geneva: World Health Organization.
16. Marti?nez Larrad MT, Ferna?ndez-Pe?rez C, Corbato?n-Anchuelo A, Gabriel R, Lorenzo C, et al. (2011) Revised waist circumference cut-off points for the criteria of abdominal obesity in the Spanish population: Multicenter nationwide Spanish population based study. Av Diabetolologia 27(5):168-174.
17. Buja A, Scafato E, Sergi G, Maggi S, Suhad MA, et al. (2010) Alcohol consumption and Metabolic Syndrome in the elderly: Results from the Italian longitudinal study on aging. Eur J Clin Nutr 64: 297-307.
18. Yoon YS, Oh SW, Baik HW, Park HS, Kim WY. (2004) Alcohol consumption and the metabolic syndrome in Korean adults: The 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr 80: 217-224.
19. Fridewald WT, Levy RI, Fredrickson D. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugue. Clin Chem 18, 499-502.
20. Diagnosis and classification of diabetes mellitus. American Diabetes Association. (2004) Diabetes Care 27: S5-10.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28: 412- 419.
22. D?Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 18: 499-502.
23. Conroy RM, Pyo?ra? la K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the Score project. Eur Heart J 24: 987-1003.
24. Aguilar-Salinas CA, Garcia EG, Robles L, Rian?o D, Ruiz-Gomez DG, et al. (2008) High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93: 4075-4079.
25. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. (2010) Metabolically healthy obesity: different prevalence using different criteria. Eur J Clin Nutr 64: 1043-1051.
26. Kuk JL, Ardern CI. (2009) Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32: 2297-2299.
27. Pajunen P, Kotronen A, Korpi-Hyo?va? lti E, Keina?nen-Kiukaanniemi S, Oksa H, et al. (2011) Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 11: 754.
28. Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110: 227-239.
29. Soriguer F, Gutie?rrez-Repiso C, Rubio-Marti?n E, Garci?a-Fuentes E, Almaraz MC, et al. (2013) Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrin Metab 98 (6): 2318-2325.
30. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, et al. (2011) Prevalence, metabolic features and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34: 210-215.
31. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. (2005) Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 13: 1116-1122.
32. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, et al. (2006) Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 30: 1529-1534.
33. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, et al. (2014) The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocrine Disorders 14: 9.
34. Jennings C L, Lambert EV, Collins M, Joffe Y, Levitt NS, et al. (2008) Determinants of insulin resistant phenotypes in normal weight and obese black African women. Obesity 16 (7): 1602-1609.
35. Lee K. (2009) Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviours. Asia Pac J Clin Nutr 18 (2): 280-284.
36. Marques-Vidal P, Velho S, Waterworth D, Waeber G, von Ka?nel R, et al. (2012) The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used. Eur J Clin Nutr 66: 426-435.
37. Basati G, Pourfarzam M, Movahedian A, Samsamshariat SZ, Sarrafzadegan N.(2011) Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients. Clinics (Sao Paulo) 66: 1129-1135.
38. Ukkola O, Santaniemi M. (2002) Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med (Berl) 80 (11): 696-702.
39. Juge-Aubry CE, Henrichot E, Meier CA. (2005) Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 19 (4): 547-566.
40. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Lo?wel H. (2006) Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently middle aged men. J Am Coll Cardiol 48: 1369-1377.
41. Ogorodnikova AD, Kim M, McGinn A, Muntner P, Khan UI, et al. (2012) Incident Cardiovascular Disease Events in Metabolically Benign Obese Individuals. Obesity 20: 651-629.
42. Arnlo?v J, Ingelsson E, Sundstro?m J, Lind L. (2010) Impact of BMI and the Metabolic Syndrome on the Risk of Diabetes in Middle-Aged Men. Circulation 121: 230-236.
43. Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, et al. (2010) Excess weight and the risk of incident coronary heart disease among men and women. Obesity 18: 377-383.